X-Linked Disorders:

Fabry Disease

 

Fabry disease is classified as a lysosomal storage disease and can be caused by multiple types of pathogenic changes in the gene GLA. GLA is located on the X chromosome and can be altered through deletions, insertions, missense or nonsense mutations, splice-site anomalies, and reassortment of the DNA. Fabry disease causes progressive damage to the heart, kidneys, skin, eyes, central nervous system, and gastrointestinal system, which can eventually lead to organ failure (16).

Fabry disease affects molecular structures within each cell called the lysosomes, which function by digesting foreign, or damaged materials, like viruses, bacteria, and old cell parts (15). GLA encodes for the α-GAL enzyme that digests globotriaosylceramide (Gb3) into galactose. When the gene stops functioning the α-GAL enzyme globotriaosylceramide (Gb3) is not produced and Gb3 accumulates within cellular lysosomes.

Citation 17: https://rarediseases.org/rare-diseases/fabry-disease ; Image created by Abbey Sayers

 

 

Written by Abigail Sayers; Images by Abigail Sayers unless otherwise noted

Reviewed and Edited by Rachel Baer, MSc, and Andy McCarty, MS, LGC, CGC

Learn More About Genetics:


15. Cooper GM. The Cell: A Molecular Approach. 2nd edition. Sunderland (MA): Sinauer Associates; 2000. Lysosomes. Available from: https://www.ncbi.nlm.nih.gov/books/NBK9953/ 

16. Bernardes, T. P., Foresto, R. D., & Kirsztajn, G. M. (2020). Fabry disease: genetics, pathology, and treatment. Revista da Associacao Medica Brasileira (1992), 66Suppl 1(Suppl 1), s10–s16. https://doi.org/10.1590/1806-9282.66.S1.10 

17. Fabry Disease. National Organization for Rare Disorders. (2019, June 6). https://rarediseases.org/rare-diseases/fabry-disease